Article Detail - JE Part B
Self-Administered Drug Exclusion List (A53032) - R27 - Effective November 01, 2022
This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Effective Date: November 01, 2022
Summary of Changes: The article is updated to add: Adbry™ (tralokinumab-ldrm) - C9399, J3490, J3590 effective 11/01/2022.
The most current version of the Self-Administered Drug Exclusion List is available on the Medicare Coverage Database (MCD).
To view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.